Doctors wary of Trump’s cocktail ‘cure’
The US President says Regeneron's treatment is behind his swift COVD-19 revovery, but doctors need more evidence
Doctors are urging caution over the experimental antibody-based drugs taken by US President Donald Trump to treat coronavirus.
President Trump, who left hospital after just three days of being treated for COVID-19, has promised to make the drug cocktail from Regeneron Pharmaceuticals Inc free to all US coronavirus patients.